Holen Sie sich die Stockscreener-App
73.00
0.65%
0.385
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$72.61
Offen:
$73.77
24-Stunden-Volumen:
277.23K
Relative Volume:
0.10
Marktkapitalisierung:
$14.24B
Einnahmen:
$4.23B
Nettoeinkommen (Verlust:
$235.80M
KGV:
61.65
EPS:
1.1841
Netto-Cashflow:
$569.50M
1W Leistung:
+1.91%
1M Leistung:
+8.52%
6M Leistung:
-12.90%
1J Leistung:
-0.29%
1-Tages-Spanne:
$72.65
$74.33
1-Wochen-Bereich:
$71.65
$74.45
52-Wochen-Spanne:
$58.89
$89.83
The Cooper Companies, Inc. Stock (COO) Company Profile
Firmenname
The Cooper Companies, Inc.
Sektor
Telefon
925-460-3600
Adresse
6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA
Compare COO vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COO
The Cooper Companies, Inc.
|
72.99 | 14.47B | 4.23B | 235.80M | 569.50M | 1.1841 |
ISRG
Intuitive Surgical Inc
|
436.26 | 150.88B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.89 | 43.56B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.10 | 36.52B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.48 | 33.97B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.27 | 30.41B | 5.54B | 1.52B | 1.74B | 10.37 |
The Cooper Companies, Inc. Stock (COO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-04 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-03 | Bestätigt | Needham | Buy |
| 2025-11-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Sell |
| 2025-08-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-22 | Hochstufung | BNP Paribas Exane | Neutral → Outperform |
| 2025-06-17 | Hochstufung | Needham | Hold → Buy |
| 2025-05-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-08-29 | Bestätigt | Piper Sandler | Overweight |
| 2024-07-16 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-19 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-03-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-30 | Eingeleitet | BofA Securities | Buy |
| 2023-10-05 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-05-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-30 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-12 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-05-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-04-08 | Eingeleitet | Needham | Hold |
| 2022-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-09-03 | Bestätigt | Citigroup | Neutral |
| 2021-09-03 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-09-03 | Bestätigt | Oppenheimer | Perform |
| 2021-09-03 | Bestätigt | Stifel | Buy |
| 2021-04-23 | Eingeleitet | Redburn | Buy |
| 2020-07-06 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2019-02-01 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-01-04 | Herabstufung | Goldman | Neutral → Sell |
| 2018-07-30 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-12-08 | Bestätigt | Stifel | Buy |
| 2017-09-12 | Bestätigt | Stifel | Buy |
| 2017-09-01 | Bestätigt | Piper Jaffray | Overweight |
| 2017-07-21 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-06-29 | Eingeleitet | Guggenheim | Neutral |
| 2017-06-02 | Bestätigt | Stifel | Buy |
| 2016-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2016-08-31 | Bestätigt | Stifel | Buy |
| 2016-06-30 | Bestätigt | Stifel | Buy |
| 2016-06-03 | Bestätigt | Jefferies | Buy |
| 2016-04-15 | Hochstufung | Jefferies | Hold → Buy |
| 2015-12-17 | Eingeleitet | Goldman | Neutral |
| 2015-12-04 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
The Cooper Companies, Inc. Aktie (COO) Neueste Nachrichten
CooperSurgical Supports Saving Mothers to Help Advance Global Women’s Health and Raise Awareness - Yahoo Finance
Biofinity Toric from CooperCompaniesmonthly lenses built for everyday astigmatism comfort - AD HOC NEWS
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure - The Manila Times
CooperCompanies discloses Scope 3 emissions in sustainability report - Stock Titan
Is COO Stock Attractive as MyDay Gains Meet Asia-Pacific Pressure - Yahoo Finance
How COO Is Riding Myopia and Fertility Trends Amid Execution Risks - The Globe and Mail
CooperCompanies trims 2026 revenue outlook as litigation weighs on margins. Nasdaq-listed medical de - AD HOC NEWS
Inside the Cooper Hewitt Smithsonian Design Museum's New Permanent Collection - WSJ
Dave Portnoy Claims Alex Cooper & Sofia Franklyn Planned to Say They Were Sexually Harassed at Barstool to Get Out of ‘Call Her Daddy’ Contract - IMDb
Eli Lilly Upgraded, Carvana Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Honeywell completes final spin-off as aerospace company starts trading on Nasdaq - The Business Journals
The Cooper Companies, Inc. (COO) - DirectorsTalk Interviews
Price to book forward of The Cooper Companies, Inc. – NASDAQ:COO - TradingView
Clariti 1 day from CooperCompaniessilicone hydrogel goes daily disposable - AD HOC NEWS
Alex Cooper Addresses Allegations Surrounding Unwell Network - okmagazine.com
CooperCompanies trims 2026 revenue guidance after Q2 beat, shares react to outlook shift - Ad-hoc-news.de
Enterprise value to EBIT forward of The Cooper Companies, Inc. – NASDAQ:COO - TradingView
Enterprise value to EBITDA forward of The Cooper Companies, Inc. – NASDAQ:COO - TradingView
Price to earnings forward of Cooper Companies, Inc. – BMV:COO - TradingView
CooperCompanies strategic pivot to eye care, shares backed by Stifel - AD HOC NEWS
How Call Her Daddy's Alex Cooper's empire is being chipped away at by her husband's mismanagement - laineygossip.com
Stifel Backs Cooper Companies (COO) as CooperSurgical Sale Talks Progress - Insider Monkey
New $23.8M 90-unit, income-restricted apartment complex opens in Warner Robins - Macon Telegraph
Biofinity toric from CooperCompaniesmonthly lenses that target astigmatism comfort - Ad-hoc-news.de
CooperCompanies gains analyst support, shares hold near recent highs - AD HOC NEWS
5 Best Stocks to Buy According to Billionaire Barry Rosenstein - Insider Monkey
CooperCompanies Tuesday consensus view, shares on Nasdaq after a recent analyst call - Ad-hoc-news.de
The Cooper Companies sets cautious 2026 guidance, shares trade steadily on Nasdaq - Ad-hoc-news.de
The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling A Potential 22% Upside - DirectorsTalk Interviews
Did Cooper Companies' Q1 Beat Mask Underlying Weakness - Kavout | AI
The Cooper Companies StockAnalyst consensus ahead of next earnings - Ad-hoc-news.de
Cooper Companies stock: Is COO underperforming the healthcare sector? - MSN
3 US Blue Chip Stocks With Earnings Growth And P E Risk - Sahm
CooperCompanies Stockanalyst consensus and sector context into the week - AD HOC NEWS
CooperCompanies rises on Q2 beat despite net loss - MSN
Cooper Companies Inc (COO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cooper Companies Inc (COO) Valuation: PE, PB & Fair Value Analysis - TradingKey
A Look at The Cooper Companies Inc (COO) After 3.4% Decline -- G - GuruFocus
Cooper Companies Inc (COO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cooper Companies Inc (COO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cooper Companies Inc (COO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cooper Companies Inc (COO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cooper Companies Inc (COO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cooper Companies Inc (COO) Institutional Confidence - TradingKey
Cooper Companies Inc (COO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
The Cooper Companies, Inc. Stock 12‑Month Price Target Cut to $78.77, Implies 17% Upside - TradingView
Stifel Adjusts Price Target on Cooper Companies to $85 From $95, Maintains Buy Rating - Moomoo
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector? - inkl
CooperCompanies Stock (US21664P1039): Technical picture in focus on a quiet news day - AD HOC NEWS
Building a Global Feedback Engine: The CooperVision Story - Atrium AI
CooperCompanies Stock (US21664P1039): Quarterly earnings in focus after latest results - AD HOC NEWS
Finanzdaten der The Cooper Companies, Inc.-Aktie (COO)
Umsatz
Nettogewinn
Free Cashflow
ENV
The Cooper Companies, Inc.-Aktie (COO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| WEISS ROBERT S | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,654 |
0 |
292,599 |
| Rivas Maria | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
3,322 |
| Jay Colleen | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
39,907 |
| Carbone Barbara | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,050 |
0 |
3,050 |
| MADDEN TERESA S | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
15,679 |
| Lucchese Cynthia L | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
12,767 |
| Kurzius Lawrence Erik | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
11,099 |
| Jay Colleen | Director |
Jan 12 '26 |
Option Exercise |
39.40 |
7,064 |
278,322 |
36,585 |
| White Albert G III | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
18,340 |
0 |
254,491 |
| Warner Gerard H III | President, CooperVision, Inc. |
Jan 08 '26 |
Option Exercise |
0.00 |
11,518 |
0 |
29,837 |
0.49%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):